Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
BMC Cancer
|
September 2, 2025
A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
Matthew T McMillan, Marsha Reyngold, Christopher H Crane, et al.
Cancers
|
January 25, 2025
Evolving Trends and Patterns of Utilization of Magnetic Resonance-Guided Radiotherapy at a Single Institution, 2018-2024
Robert A Herrera, Eyub Y Akdemir, Rupesh Kotecha, et al.
Frontiers in Oncology
|
July 11, 2022
Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer
Michael D Chuong, Roberto Herrera, Adeel Kaiser, et al.
Advances in Radiation Oncology
|
December 9, 2022
Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy
Michael D Chuong, Roberto Herrera, Antonio Ucar, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
January 4, 2023
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
J M Bryant, Russell F Palm, Roberto Herrera, et al.
Cancers
|
August 14, 2025
Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic Cancer
Michael D Chuong, Eileen M O'Reilly, Robert A Herrera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2026
Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma
Michael D Chuong, Roberto Herrera, Jason E Extein, et al.
Advances in Radiation Oncology
|
June 1, 2022
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy<sub>10</sub> for Non-bone Oligometastases
Tugce Kutuk, Robert Herrera, Teuta Z Mustafayev, et al.
Frontiers in Oncology
|
June 20, 2019
Consensus Report From the Miami Liver Proton Therapy Conference
Michael D Chuong, Adeel Kaiser, Fazal Khan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 6, 2025
Proton Beam Therapy for Pancreatic Tumors: A Consensus Statement from the Particle Therapy Cooperative Group Gastrointestinal Subcommittee
Arpit M Chhabra, Richard A Amos, Charles B Simone, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
BMC Cancer
|
September 2, 2025
A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
Matthew T McMillan, Marsha Reyngold, Christopher H Crane, et al.
Cancers
|
January 25, 2025
Evolving Trends and Patterns of Utilization of Magnetic Resonance-Guided Radiotherapy at a Single Institution, 2018-2024
Robert A Herrera, Eyub Y Akdemir, Rupesh Kotecha, et al.
Frontiers in Oncology
|
July 11, 2022
Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer
Michael D Chuong, Roberto Herrera, Adeel Kaiser, et al.
Advances in Radiation Oncology
|
December 9, 2022
Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy
Michael D Chuong, Roberto Herrera, Antonio Ucar, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
January 4, 2023
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
J M Bryant, Russell F Palm, Roberto Herrera, et al.
Cancers
|
August 14, 2025
Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic Cancer
Michael D Chuong, Eileen M O'Reilly, Robert A Herrera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2026
Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma
Michael D Chuong, Roberto Herrera, Jason E Extein, et al.
Advances in Radiation Oncology
|
June 1, 2022
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy<sub>10</sub> for Non-bone Oligometastases
Tugce Kutuk, Robert Herrera, Teuta Z Mustafayev, et al.
Frontiers in Oncology
|
June 20, 2019
Consensus Report From the Miami Liver Proton Therapy Conference
Michael D Chuong, Adeel Kaiser, Fazal Khan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 6, 2025
Proton Beam Therapy for Pancreatic Tumors: A Consensus Statement from the Particle Therapy Cooperative Group Gastrointestinal Subcommittee
Arpit M Chhabra, Richard A Amos, Charles B Simone, et al.
Page
of 5